49
Views
0
CrossRef citations to date
0
Altmetric
Device Evaluation

Improved Transfemoral Accessibility and Positioning of the Portico Transcatheter Heart Valve With the New FlexNav Delivery System

ORCID Icon, , , , , & show all
Pages 619-624 | Received 06 Dec 2020, Accepted 27 Jan 2021, Published online: 18 Feb 2021

References

  • Popma JJ , DeebGM, YakubovSJet al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N. Engl. J. Med., 380(18), 1706–1715 (2019).
  • Barbanti M , BuccheriS, Rodes-CabauJet al. Transcatheter aortic valve replacement with new-generation devices: a systematic review and meta-analysis. Int. J. Cardiol., 245, 83–89 (2017).
  • Leon MB , SmithCR, MackMJet al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N. Engl. J. Med., 374(17), 1609–1620 (2016).
  • Baumgartner H , FalkV, BaxJJet al. ESC/EACTS guidelines for the management of valvular heart disease. Eur. Heart J., 38(36), 2739–2791 (2017).
  • Grover FL , VemulapalliS, CarrollJDet al. 2016 annual report of the society of thoracic surgeons/american college of cardiology transcatheter valve therapy registry. J. Am. Coll. Cardiol., 69(10), 1215–1230 (2017).
  • Tagliari AP , VicentiniL, ZimmermannJMet al. Transcatheter aortic valve neo-commissure alignment with the portico system. EuroIntervention doi:10.4244/EIJ-D-20-01095 (2020) ( Epub ahead of print).
  • Abbott data on file. 90598280.
  • Makkar RR , ChengW, WaksmanRet al. Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial. Lancet, 396(10252), 669–683 (2020).
  • Fontana GP on behalf of the PORTICO IDE investigator . PORTICO: a randomized trial of portico vs commercially available transcatheter aortic valves in patients with severe aortic stenosis. TCT (2019).
  • Fontana GP , BedogniF, GrohMet al. Safety profile of an intra-annular self-expanding transcatheter aortic valve and next-generation low-profile delivery system. JACC Cardiovasc. Interv., 3(21), 2467–2478 (2020).
  • Gorla R , DeMarco F, GarattiAet al. Impact of aortic angle on transcatheter aortic valve implantation outcome with Evolut-R, Portico, and Acurate-NEO. Catheter Cardiovasc. Interv. doi:10.1002/ccd.28957 (2020) ( Epub ahead of print).
  • Casenghi M , GorlaR, PopoloRubbio Aet al. One-year safety and efficacy profile of transcatheter aortic valve-in-valve implantation with the portico system. Catheter Cardiovasc. Interv. doi:10.1002/ccd.29353 (2020) ( Epub ahead of print).
  • Portico NG Approval Study. ( Identifier: NCT04011722). ClinicalTrials.gov

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.